This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Melmed, S. Search for Related Content PubMed PubMed Citation Articles by Melmed, S.

Isolation of Human-Mouse Somatic Cell Hybrids Producing Human Prolactin: Dominant Expression of Hormone Secretion and Regulation^*

Shlomo Melmed

Division of Endocrinology, Department of Medicine, Cedars-Sinai Medical Center-UCLA School of Medicine, Los Angeles, California 90048

Address all correspondence and requests for reprints to: Dr. Shlomo Melmed, Division of Endocrinology, Room 516 Schuman Building, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, California 90048.

Human PRL (hPRL)-secreting adenoma cells obtained at hypophysectomy were fused with a mutant mouse fibroblast line (LMTK^–) which is aminopterin sensitive due to a deficiency in the enzyme thymidine kinase. After fusion with polyethylene glycol, cells containing nuclear material from the two parental lines (heterokaryons) were selected in medium containing hypoxanthine, aminopterin, and thymidine, and resultant clones were screened for hPRL secretion. Functional human x mouse somatic cell hybrid clones secreting hPRL were isolated in order to study hPRL gene expression and regulation. Positive hybrid clones were subcultured and have sustained hPRL secretion. The hybrid nature of the cells was confirmed by fibroblastic morphology resembling the mouse parental cell, mixed karyotype of mouse and human chromosomes, and mixed isozyme banding pattern for human and mouse glucoses-phosphate dehydrogenase and malic enzyme. Specific expression of the hPRL gene was demonstrated by the presence of electron microscopic secretory granules (650–800 nm), positive immunoperoxidase staining using anti-hPRL serum, and sustained secretion of immunoreactive hPRL, which comigrated with [¹²⁵I] hPRL standard on Sephadex chromatography. Hormonal modulation of hPRL gene expression by TRH was dominantly expressed in the hybrid cell. Human chromosome 6 was identified in hybrid cells secreting hPRL, and the cells expressed human malic enzyme, a marker for this chromosome, thus confirming the chromosome assignment of the hPRL gene. The results show that functional replicating hybrids secreting hPRL can be isolated. The technique provides a useful in vitro model for the study of hPRL gene expression and modulation. (J Clin Endocrinol Metab 56: 1145, 1983)

^* This work was supported in part by a BioScience Laboratories Fellowship and NIH Biomedical Research Support Grant RR-05468.

Recipient of Clinical Investigator Award AM-00906 from the NIADDKD, NIH.

Received July 1, 1982.

This article has been cited by other articles:

				S. MELMED, G. D. BRAUNSTEIN, J. R. CHANG, and D. P. BECKER Pituitary Tumors Secreting Growth Hormone and Prolactin Ann Intern Med, August 1, 1986; 105(2): 238 - 253. [Abstract] [PDF]